Access cutting-edge transthyretin amyloidosis treatment through this clinical trial at a research site in Jacksonville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Jacksonville location
Access transthyretin amyloidosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related transthyretin amyloidosis treatment provided free
Check if you qualify for this transthyretin amyloidosis clinical trial in Jacksonville, FL
No-Cost Study Care
Local to Jacksonville
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that accumulates in different organs in the body and can cause damage to the organ. There are two ways that the TTR protein can fall apart. One way occurs as a person ages, where the normal TTR protein can fall apart and form amyloid that may no longer be sufficiently cleared by the body. This type of ATTR is known as wild-type ATTR
Sponsor: Eidos Therapeutics, a BridgeBio company
Yes, this clinical trial (NCT06563895) has an active research site in Jacksonville, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for transthyretin amyloidosis treatment options in Jacksonville, FL, this clinical trial (NCT06563895) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Jacksonville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced transthyretin amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all transthyretin amyloidosis clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Jacksonville — not just this study.
Browse Essential Tremor Trials in Jacksonville →